Skip to main content

Gary S Firestein

NIH Rank #251
  • Program Leader
  • Top 5% Funded
  • R01 Holder
  • Early Career
  • Mentor
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1864505Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Internal Medicine
  • CHEMISTRY

NIH Funding · FY2024

Linked Award Amount
$12.1M
Full award amounts, FY2024
Award Records
6
Records listing this PI
Award-Linked Rank
#251
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Gary S Firestein. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Gary S Firestein as a PI. Multi-PI records show the full award amount for context.

  • 5UL1TR001442-10UL1
    UC San Diego Clinical and Translational Research Institute
    $9.2M
    award amount
  • 5U01AR079717-03U01
    Methotrexate treatment of Arthritis caused by Chikungunya virus (MARCH): A randomized controlled trial of methotrexate versus placebo in the treatment of chronic arthritis after chikungunya infection
    $1.5M
    award amount
  • 5R01AR065466-10R01
    Identification of key regulators in rheumatoid arthritis
    $555.1K
    award amount
  • 2T32AR064194-11T32
    Rheumatic Diseases Research Training Grant
    $376K
    award amount
  • 3UL1TR001442-10S1UL1
    UC San Diego Clinical and Translational Research Institute
    $216.9K
    award amount
  • 3U01AR079717-03S1U01
    Methotrexate treatment of Arthritis caused by Chikungunya virus (MARCH): A randomized controlled trial of methotrexate versus placebo in the treatment of chronic arthritis after chikungunya infection
    $148.4K
    award amount

Award organizations

Organizations that administered FY2024 awards listing Gary S Firestein as a PI.

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of California, San Diego
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    $5M Cumulative Funding
  6. 2024
    $10M Cumulative Funding
  7. 2024
    Entered Top 50% Nationally
    Ranked #251
  8. 2024
    Entered Top 25% Nationally
    Ranked #251
  9. 2024
    Entered Top 10% Nationally
    Ranked #251
  10. 2024
    Entered Top 5% Nationally
    Ranked #251
  11. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  12. 2025
    R01 Grant Holder
  13. 2025
    Program/Center Grant Leader